Abstract
Autonomic imbalance, through differential effects of catecholamines, has long been hypothesized as a major mechanism leading to a number of clinical disorders, particularly those involving the heart [1]. The largest source of catecholamines is found in the sympathetic nerves of the heart, which are distributed on a regional basis [2]. Only in the past few years has it been possible to evaluate abnormalities in heart innervation in the intact animal. Recent developments in cardiac imaging have led to the ability to map the distribution of the sympathetic nerves in vivo. As a result, the pathophysiologic mechanisms relating alterations in sympathetic nerve activity to disease processes are now being explored.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Manger WM. Adrenergic involvement in cardiac pathophysiology. Adv Cardiol 1982; 30: 74–107.
Randall WC. Nervous control of cardiovascular function. New York: Oxford University Press, 1984.
Whitby LG, Axelrod J, Weil-Malherbe H. The fate of 3H-norepinephrine in animals. J Pharmacol Exp Ther 1961; 132: 193–201.
Iversen LL. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 1971; 41: 571–91.
Lightman SL, Iversen LL. The role of uptake in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol 1969; 37: 638–49.
Kopin I. False adrenergic transmitters. Annu Rev Pharmacol 1968; 8: 377–94.
Wieland DM, Wu JL, Brown LE, Mangner TJ, Swanson DP, Beierwalters WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with (131-1) Iodoben-zylguanidine. J Nucl Med 1980; 21: 349–53.
Kline RC, Swanson DP, Wieland DM et al. Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med 1981; 22: 129–32.
Manger WM, Hoffman BB. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake [editorial]. J Nucl Med 1983; 24: 1194–6.
Wieland DM, Brown LE, Rogers WL et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981; 22: 22–31.
Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987; 28: 1620–4.
Dae MW, O’Connell W, Chin MC, Herre JM, Huberty JP, Botvinick EH. Scintigraphic assessment of global adrenergic nerve density with MIBG washout maps [abstract]. J Am Coll Cardiol 1988; 11(2 Suppl A): 214A.
Sisson JC, Bolgas G, Johnson J. Measuring acute changes in adrenergic nerve activity of the heart in the living animal. Am Heart J 1991; 121: 1119–23.
Dae MW, O’Connell JW, Botvinick EH et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989; 79: 634–44.
Sisson JC, Lynch JJ, Johnson J et al. Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 1988; 116: 67–76.
Mori H, Pisarri TE, Aldea GS et al. Usefulness and limitations of regional cardiac sympathectomy by phenol. Am J Physiol 1989; 257: H1523–33.
Barber MJ, Mueller TM, Henry DP, Feiten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983; 67: 787–96.
Herre J, Wetstein L, Lin YL, Mills AS, Dae M, Thames MD. Effect of transmural versus nontransmural myocardial infarction on inducibility of ventricular arrhythmias during sympathetic stimulation. J Am Coll Cardiol 1988; 11: 414–21.
Dae M, Herre J, O’Connell J, Botvinick E, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991; 17: 1416–23.
Minardo JD, Tuli MM, Mock BH et al. Scintigraphic and electrophysiologic evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988; 78: 1008–19.
Inoue H, Zipes D. Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation 1987; 75: 877–87.
Dae MW, DeMarco T, Botvinick EH, Hattner RH, Ratzlaff NW, Huberty JH. Absence of extraneuronal uptake of MIBG following cardiac transplantation [abstract]. J Nucl Med 1990; 31: 792.
Dae M, Herre J, Botvinick E et al. Scintigraphic assessment of adrenergic innervation after myocardial infarction [abstract]. Circulation 1986; (4 Suppl II): II 297.
Stanton MS, Tuli MM, Radtke NL et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989; 14: 1519–26.
Sisson JC, Shapiro B, Meyers L et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625–36.
Nakajo M, Shimabukuro K, Miyaji N et al. Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma. J Nucl Med 1985; 26: 357–65.
Henderson EB, Kahn JK, Corbett JR et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192–9.
Taki J, Nakajima K, Bunko H, Simizu M, Muramori A, Hisada K. Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart. Eur J Nucl Med 1990; 17: 264–8.
Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252–8.
Richalet J, Merlet P, Bourguignon J et al. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 1990; 31: 34–7.
Gohl K, Feistel H, Weikl A, Bachman K, Wolf F. Congenital myocardial sympathetic dysinnervation — a structural defect of idiopathic long QT syndrome. PACE 1991; 14: 1544–53.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Dae, M.W. (1992). Scintigraphic assessment of cardiac innervation using iodine-123 metaiodobenzylguanidine. In: van der Wall, E.E., Sochor, H., Righetti, A., Niemeyer, M.G. (eds) What’s New in Cardiac Imaging?. Developments in Cardiovascular Medicine, vol 133. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2456-0_28
Download citation
DOI: https://doi.org/10.1007/978-94-011-2456-0_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5083-8
Online ISBN: 978-94-011-2456-0
eBook Packages: Springer Book Archive